Medicus Pharma (MDCXW) Accounts Payables (2023 - 2025)

Medicus Pharma has reported Accounts Payables for 3 years, with the latest figure at $3.4 million in Q4 2025.

• For the quarter ending Q4 2025, Accounts Payables rose 167.42% year-over-year to $3.4 million; the trailing twelve-month figure through Dec 2025 stood at $3.4 million (up 167.42% YoY), and the FY2025 full-year result was $3.4 million, up 167.42% from the prior year.
• Accounts Payables for Q4 2025 stood at $3.4 million, up from $2.0 million in the prior quarter.
• The five-year high for Accounts Payables was $3.4 million in Q4 2025, with the low at $210842.0 in Q4 2023.
• Historically, Accounts Payables has averaged $1.8 million across 3 years, with a median of $1.9 million in 2025.
• Annual changes were most pronounced in 2024 — Accounts Payables jumped 509.28% — and 2025, when it jumped 167.42%.
• Medicus Pharma's Accounts Payables stood at $210842.0 in 2023, then jumped by 509.28% to $1.3 million in 2024, then jumped by 167.42% to $3.4 million in 2025.
• The last three Accounts Payables figures came in at $3.4 million (Q4 2025), $2.0 million (Q3 2025), and $1.8 million (Q2 2025), per Business Quant data.